Not finding what you're looking for? Articles from older issues of Proto can be found here.
Tropical diseases thrive little noticed and unaddressed in the poorest areas of the United States.
An infectious disease tends to get attention in this country only after it starts scaring people in the suburbs of the Northeast. Today, that fear has arrived in the blood-filled gut of the urban-dwelling, daytime-biting mosquito, Aedes aegypti. The insect can carry several viral diseases—yellow fever, dengue fever, chikungunya—that had traditionally been co...
A new generation of cancer treatments harness an internal ally—the power of the immune system.
Proto's first 10 years saw policy reforms, genomic gains and a deluge of new data. What next?
Burnout is on the rise among doctors. Is medical school the place to make a difference?
Ten years ago, researchers coaxed normal adult cells into stem cells for the first time
Telehealth programs are changing how people get better—and sometimes the way they die.
The homeless are the most vulnerable population in the country. How can health care reach them?
A new way to understand and treat hearing loss comes from the deep waters of comparative biology.
Drug prices are increasing at a historic rate. Should (and can) they be capped?
One recent diagnostic advance may be guilty of stalling the fight against food-borne illness.
After major breakthrough in gene editing, pig organs show new promise for use in humans.
Xóchitl Castañeda looks for the immigrants invisible to the U.S. health care system.
Jack Geiger discusses the importance of physician activism in promoting community health
A mother details her internal struggles during her son's battle with clinical depression
A photography exhibit profiles veterans who return home with life-altering wounds.
The quest to find an objective measure for physical pain may be getting closer to its goal.
Which U.S. president left the biggest mark on modern medicine? Four historians cast their votes.
Drug-resistant bugs have spurred research into a promising—and surprisingly simple—treatment.
Research on chemical treatments for cancer began in the ashes of a world war.
The beloved author’s first great gift to children was medical, not literary.
A Boston lab looks to the plucky and omnipresent red blood cell for a new generation of therapies.
Does the body have a hidden highway between a mother’s digestive tract and the milk she produces?
Advances in pacemaker technology are making the devices safer, smaller and longer-lived.
Advocates rally around a new standard for cancer drug pricing. But will it have the desired effect?
A special kind of synesthesia helps physician Joel Salinas feel what his patients feel.
A Proto feature about changing screening protocols draws a vigorous response.
Will rent-by-the-hour robotic labs change the way that medical research happens?
The teaching cadaver is as old as the study of medicine. Is there a better alternative?
A graph that outlines the gap between physician supply and demand between 2013 and 2035.
When it comes to the cost of treatments, hospitals struggle to give customers a straight answer.
The misuse of opioid painkillers has become a major health crisis. How can the tide be turned?
A new approach for restoring blood flow to the brain is having unprecedented success.
MGH researcher Biju Parekkadan may have discovered a breakthrough treatment for this global killer.
Wilhelm Röntgen stumbled upon one of medicine’s first imaging techniques 120 years ago.
New approaches can combat the steep costs of caring for dementia patients.
New digital systems can help keep infectious agents at arm’s length—or further away.
A cross disciplinary approach has begun to pay dividends for endometriosis research.
An artist and physician team up to examine the role of acting in the clinical setting
Infectious disease specialist Martin Hirsch looks at the worry over H5N1 and its aftermath.
Neurologist Lee Schwamm looks at 10 pivotal years in the treatment of stroke victims.
The first issue of Proto looked at the genetic roots of mental illness. What’s happened since then?
Nobel laureate Jack Szostak reflects on the future of science in the United States.
In this video, MGH researcher Alessio Fasano distills fact from fiction in the gluten wars.
MGH tests new waters with its pioneer program for “complex” patients.
The storied award from MGH goes to a molecular biologist breaking new ground in cancer genetics.
MGH’s pioneering telestroke network brings virtual consultations to outlying hospitals
Hundreds of alarms compete for a clinician's attention. Can less noise mean better care?
Artists use medical scans of tumors to make stunning, informative sculptures
